Rossari Biotech Ltd
BSE:543213
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rossari Biotech Ltd
BSE:543213
|
IN |
|
N
|
Nano Co Ltd
KOSDAQ:187790
|
KR |
|
S
|
Smartone Telecommunications Holdings Ltd
F:SMA
|
HK |
|
Nexa Resources SA
NYSE:NEXA
|
LU |
|
China Securities Co Ltd
F:CS0
|
CN |
|
B
|
BriQ Properties REIC
ATHEX:BRIQ
|
GR |
|
Teleperformance SE
OTC:TLPFY
|
FR |
|
D-Wave Quantum Inc
MIL:1QBTS
|
CA |
|
G
|
GDS Holdings Ltd
NASDAQ:GDS
|
CN |
|
MEI Pharma Inc
NASDAQ:LITS
|
US |
|
S
|
SEB SA
LSE:0MGS
|
FR |
|
M
|
Matador Resources Co
SWB:7MR
|
US |
|
S
|
Sub Sri Thai Real Estate Investment Trust
SET:SSTRT
|
TH |
|
Redflow Ltd
ASX:RFX
|
AU |
|
D
|
Danone SA
BMV:BNN
|
FR |
|
M
|
Metro Bank PLC
F:6MB
|
UK |
|
C
|
Cuscal Ltd
ASX:CCL
|
AU |
|
WM Technology Inc
OTC:MAPS
|
US |
|
Informatica Inc
NYSE:INFA
|
US |
|
Safehold Inc
NYSE:SAFE
|
US |
|
Burford Capital Ltd
NYSE:BUR
|
GG |
|
M
|
Medibank Private Ltd
OTC:MDBPF
|
AU |
|
Prestige Estates Projects Ltd
NSE:PRESTIGE
|
IN |
|
E
|
Elvalhalcor Hellenic Copper and Aluminium Industry SA
ATHEX:ELHA
|
GR |
Reverse DCF
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|